COVID-19 vaccine trackerand landscape. (n.d.). Retrieved June6, 2021, fromhttps://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines Landscape ofobservational study designs on the effectiveness of COVID-19 vaccination.(n.d.). Retrieved June 6, 2021, fromhttps:...
7. Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021. 8. He Z, Ren L, Yang J, Guo L, Feng L, Ma C, et al. Seroprevalence and humoral immune durab...
Two major variants of the virus that causes COVID-19 have emerged in recent weeks, raising questions about their contagiousness and accuracy of testing – but neither is more dangerous than the virus that has circulated for the last year, experts say, and available vaccines should remain effecti...
(SARS-CoV-2),or other causes is unknown.Methods:We used data for 8,690,825 adults in New York State to assess the effectiveness of the BNT162b2,mRNA-1273,and Ad26.COV2.S vaccines against laboratory-confirmed Covid-19 and hospitalization with Covid-19(i.e.,Covid-19 diagnosed at or ...
[2]Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med, 2021, 385: 585-594 [3] Sterne JAC, Murthy S, Diaz JV, et al. Assoc...
[10] Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al. Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection— increasing community access to testing program, United States, September–November 2022. MMWR Morb Mortal Wkly Rep 2022; published online Nov 22. htt...
[10] Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al. Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection— increasing community access to testing program, United States, September–November 2022. MMWR Morb Mortal Wkly Rep 2022; published online Nov 22. htt...
COVID-19 vaccine trackerand landscape. (n.d.). Retrieved June6, 2021, from https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines Landscape ofobservational study designs on the effectiveness of COVID-19 vaccination.(n.d.). Retrieved June 6, 2021, from http...
In the U.S., three additional COVID-19 vaccines are currently in some stage of phase 3 trials or will enter very soon. Several other phase 3 trials are ongoing worldwide. If they demonstrate effectiveness and safety, more of the vaccines under development may ultimately be released. ...
(MIS-C), long-COVID syndrome3,4and downstream effects of COVID-19, including social isolation and interruption in education4. Therefore, there is an urgent need to collect more data on the effectiveness of vaccines, especially in the Omicron period, to guide decision-makers in adopting ...